162 related articles for article (PubMed ID: 26149492)
1. [The diseased vitreous body: Malformations, developmental disorders and opacities].
Kirchhof B
Ophthalmologe; 2015 Jul; 112(7):559-63. PubMed ID: 26149492
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of hyaloid-retinal relationship during triamcinolone-assisted vitrectomy for primary rhegmatogenous retinal detachment.
Sundar D; Takkar B; Venkatesh P; Chawla R; Temkar S; Azad SV; Vohra R
Eur J Ophthalmol; 2018 Sep; 28(5):607-613. PubMed ID: 29569478
[TBL] [Abstract][Full Text] [Related]
3. Juvenile retinal detachment as a complication of familial exudative vitreoretinopathy.
van Nouhuys CE
Fortschr Ophthalmol; 1989; 86(3):221-3. PubMed ID: 2759534
[TBL] [Abstract][Full Text] [Related]
4. [Familial exudative vitreoretinopathy].
Bilandarli LSh; Saidova LKh
Vestn Oftalmol; 2012; 128(5):61-4. PubMed ID: 23210352
[TBL] [Abstract][Full Text] [Related]
5. Posterior hyaloid contracture in pediatric vitreoretinopathies.
Joshi MM; Ciaccia S; Trese MT; Capone A
Retina; 2006 Sep; 26(7 Suppl):S38-41. PubMed ID: 16946676
[TBL] [Abstract][Full Text] [Related]
6. [The role of the vitreous body in diseases of neighboring structures].
Gekeler K; Priglinger S; Gekeler F; Priglinger C
Ophthalmologe; 2015 Jul; 112(7):564-71. PubMed ID: 26142226
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and surgical management of familial exudative vitreoretinopathy-associated rhegmatogenous retinal detachment.
Chen SN; Hwang JF; Lin CJ
Retina; 2012 Feb; 32(2):220-5. PubMed ID: 22277905
[TBL] [Abstract][Full Text] [Related]
8. Vitrectomy for rhegmatogenous or tractional retinal detachment with familial exudative vitreoretinopathy.
Ikeda T; Fujikado T; Tano Y; Tsujikawa K; Koizumi K; Sawa H; Yasuhara T; Maeda K; Kinoshita S
Ophthalmology; 1999 Jun; 106(6):1081-5. PubMed ID: 10366074
[TBL] [Abstract][Full Text] [Related]
9. [Intraocular surgery for secondary retinal detachment in proliferative vitreoretinopathy].
Pournaras CJ; Donati G
Klin Monbl Augenheilkd; 1995 May; 206(5):339-42. PubMed ID: 7609381
[TBL] [Abstract][Full Text] [Related]
10. [Clinical risk factors of vitreoretinal proliferations in rhegmatogenous retinal detachment].
Bonnet M
J Fr Ophtalmol; 1994; 17(8-9):530-40. PubMed ID: 7989662
[TBL] [Abstract][Full Text] [Related]
11. [Outcome after vitrectomy in rhegmatogenous retinal detachment and dense vitreous opacities].
Hoerauf H; Roider J; Herboth T; Hager A; Laqua H
Klin Monbl Augenheilkd; 1997 Dec; 211(6):369-74. PubMed ID: 9498187
[TBL] [Abstract][Full Text] [Related]
12. An endoscopic overview of the anterior vitreous base in retinal detachment and anterior proliferative vitreoretinopathy.
Boscher C; Kuhn F
Acta Ophthalmol; 2014 Jun; 92(4):e298-304. PubMed ID: 24428936
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis and therapy of traction detachment in various retinal vascular diseases.
Machemer R; Williams JM
Am J Ophthalmol; 1988 Feb; 105(2):170-81. PubMed ID: 3341435
[TBL] [Abstract][Full Text] [Related]
14. [Contractile elements in proliferative retinal diseases].
Molitor R; Esser P; Weller M; Wiedemann P; Heimann K
Ophthalmologe; 1992 Feb; 89(1):34-8. PubMed ID: 1581690
[TBL] [Abstract][Full Text] [Related]
15. [Onset and progression of proliferative vitreoretinopathy as viewed from the system approach].
Krivosheina OI; Zapuskalov IV
Vestn Oftalmol; 2004; 120(4):44-6. PubMed ID: 15384853
[No Abstract] [Full Text] [Related]
16. Components of the fibrinolytic system in the vitreous body in patients with vitreoretinal disorders.
Ulrich JN; Spannagl M; Kampik A; Gandorfer A
Clin Exp Ophthalmol; 2008 Jul; 36(5):431-6. PubMed ID: 18939350
[TBL] [Abstract][Full Text] [Related]
17. [Familial exudative vitreoretinopathy associated with persistence of hyaloid artery].
Errais K; Ammous I; Kamoun R; Mili Boussen I; Anene R; Zhioua R; Meddeb Ouertani A
J Fr Ophtalmol; 2008 Jan; 31(1):e3. PubMed ID: 18401292
[TBL] [Abstract][Full Text] [Related]
18. Congenital retinal fold as a sign of dominant exudative vitreoretinopathy.
van Nouhuys CE
Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 217(1):55-67. PubMed ID: 6911005
[TBL] [Abstract][Full Text] [Related]
19. Chemokine CXCL-1: activity in the vitreous during proliferative vitreoretinopathy.
Symeonidis C; Androudi S; Georgalas I; Tzamalis A; Chalvatzis N; Rotsos T; Souliou E; Diza E; Dimitrakos SA
Clin Exp Immunol; 2015 Aug; 181(2):338-42. PubMed ID: 25766782
[TBL] [Abstract][Full Text] [Related]
20. [Vitrectomy in proliferative vitreoretinopathy. Anatomical and functional results in 501 patients].
Körner F; Böhnke M
Klin Monbl Augenheilkd; 1995 Apr; 206(4):239-45. PubMed ID: 7791283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
